Document Classification

Section Type: RESULTS

Text: In Cox regression models controlling for treatment type, baseline Framingham risk score, baseline and in-treatment blood pressure, and severity of baseline electrocardiographic LVH by Cornell product and Sokolow-Lyon voltage, less-severe in-treatment LVH by Cornell product and Sokolow-Lyon voltage were associated with 14 % and 17 % lower rates, respectively, of the composite CV end point (adjusted hazard ratio [HR], 0. 86 ; 95 % confidence interval [CI], 0. 82-0. 90 ; P <. 001 for every 1050-mm x ms [1-SD] decrease in Cornell product ; and HR, 0. 83 ; 95 % CI, 0. 78-0. 88 ; P <. 001 for every 10. 5-mm [1-SD] decrease in Sokolow-Lyon voltage).